Megan M. Mantica

Megan M. Mantica

Neurology

5115 Centre Avenue, Hillman Cancer Center, 2nd Floor
Pittsburgh, PA 15232

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Clinical outcomes after transition from weight-based to fixed-dose glucarpidase for high-dose methotrexate toxicity at a large academic medical center.

Clinical outcomes after transition from weight-based to fixed-dose glucarpidase for high-dose methotrexate toxicity at a large academic medical center.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: July 09, 2026

Erratum: Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Erratum: Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 07, 2026

Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 14, 2026

Predictors of diagnostic yield and surgical safety in stereotactic brain biopsy.

Predictors of diagnostic yield and surgical safety in stereotactic brain biopsy.

Journal: Journal of neuro-oncology

Published: January 28, 2026

Clinical characteristics and outcomes of adult IDH-mutant brainstem gliomas: Institutional case series and systematic review.

Clinical characteristics and outcomes of adult IDH-mutant brainstem gliomas: Institutional case series and systematic review.

Journal: Neuro-oncology advances

Published: December 05, 2025

Perioperative Management of Targeted and Immunologic Agents in Neurosurgical Oncology.

Perioperative Management of Targeted and Immunologic Agents in Neurosurgical Oncology.

Journal: Neurosurgery

Published: August 29, 2025

Treatment strategies and innovation for recurrent high-grade glioma.

Treatment strategies and innovation for recurrent high-grade glioma.

Journal: Journal of neuro-oncology

Published: August 15, 2025

Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations.

Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations.

Journal: medRxiv : the preprint server for health sciences

Published: August 08, 2025

Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations.

Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations.

Journal: The oncologist

Published: July 19, 2025

Corticosteroid Use Before Stereotactic Brain Biopsy for Suspected Lymphoma.

Corticosteroid Use Before Stereotactic Brain Biopsy for Suspected Lymphoma.

Journal: Neurosurgery

Published: May 13, 2025

MYCN drives pediatric glioma transformation from neural progenitors and creates distinct therapeutic vulnerabilities.

MYCN drives pediatric glioma transformation from neural progenitors and creates distinct therapeutic vulnerabilities.

Journal: Cell reports

Published: April 08, 2025

Impact of Surgical Ventricular Entry on Survival Outcomes in IDH-Mutant Gliomas.

Impact of Surgical Ventricular Entry on Survival Outcomes in IDH-Mutant Gliomas.

Journal: Neurosurgery

Published: April 03, 2025

Showing 1-12 of 20

Last Updated: 09/26/2026